S Ullrich, C Nitsche - Bioorganic & medicinal chemistry letters, 2020 - Elsevier
… ideal drugtarget because, to the best of our knowledge, no human host-cell proteases are known with this substrate specificity.59, 60, 61 Viral proteases are well validated drugtargets …
C Wu, Y Liu, Y Yang, P Zhang, W Zhong… - … Pharmaceutica Sinica B, 2020 - Elsevier
… inhibitors, Nsp12-RdRp has been used as a very important drugtarget. In principle, targeted inhibition of Nsp12-RdRp could not cause significant toxicity and side effects on host cells, …
… protein drugtargets of SARS-CoV-2 and their structures, including the drugtarget class and its … We have also discussed several drug discovery approaches and associated protein drug …
… , such as viral proteins of SARS-CoV-2. We … SARS-CoV-2 with the hope that effective drugs can be developed based on these AI-proposed drug candidates and act against SARS-CoV-2…
… for SARS-CoV-2 host interactome exploration and drug (target) … -protein interactions, and drug-target interactions. It allows … In summary, with CoVex, we found a new drugtarget that …
… A multitarget treatment approach with synergistic drug combinations containing different … against SARS-CoV-2. This review highlights the anti–SARS-CoV-2 drugtargets and therapeutic …
Y Zhang, LV Tang - Journal of proteome research, 2020 - ACS Publications
… NSP13 can be considered as a drugtarget against COVID-19. (94) … to SARS-CoV-2 replication cycle targets and drugs in PubMed, finding that the SARS-CoV-2 replication cycle targets …
… For the discovery of novel drug-like compounds, we screened compounds structurally similar to Galidesivir that may targetSARS-CoV-2 RdRp as an antiviral agent. The best hits—…
M Chien, TK Anderson, S Jockusch, C Tao… - Journal of proteome …, 2020 - ACS Publications
… by the SARS-CoV-2 RdRp, a well-established drugtarget for … -approved hepatitis C drug) is incorporated by SARS-CoV-2 … an inhibitor of the SARS-CoV and SARS-CoV-2 RdRp using …